Morgan Stanley Says Hipages Needs Faster Growth for Rerating
Morgan Stanley analysts say Hipages needs stronger revenue growth and EBITDA margin expansion for its stock to rerate, while describing the business as well-run and profitable.
Morgan Stanley analysts say Hipages needs stronger revenue growth and EBITDA margin expansion for its stock to rerate, while describing the business as well-run and profitable.